Latest News

The Westwood Salient Enhanced Midstream Income ETF targets high current income and capital appreciation via common equities of U.S. and Canadian midstream companies. MDST employs a covered call strate

New York, New York--(Newsfile Corp. - September 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Wix.com Ltd. (NASDAQ: WIX) between February 19,

The 10-year Treasury yield has climbed sharply over the past year, rising from roughly 4.0% last October to nearly 4.9% by mid-September 2026. The more interesting story, however, is not that yields i

Reddit (RDDT) is a unique, subreddit driven social media platform that cannot be easily replicated. Targeted advertising following users' explicit interests and intent within subreddits is far more va

New York, New York--(Newsfile Corp. - September 22, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Com

European natural gas inventories are at lows not seen since 2021, right before the 2022 energy crisis started. As a result of that crisis, 2022 was a rare down year for the S&P 500, with a sizable 18%

Mutual Housing California's Fairview Terrace will help income-qualified older adults in San Joaquin County find stable, affordable housing and remain connected to the community they call home STOCKTON

Advanced Micro Devices, Inc. has rallied roughly 30% since my previous coverage as investors reprice its expanding AI infrastructure opportunity. Agentic AI expands AMD's CPU opportunity, while manage

Applied Materials is upgraded to a buy as valuation has corrected while fundamentals have strengthened, creating an attractive risk/reward setup. AI-driven demand is accelerating Applied Materials' gr

Micron Technology, Inc. is set to deliver eye-popping earnings, driven by surging DRAM and NAND pricing well above historical levels. Despite robust fundamentals and massive free cash flow potential,

Pfizer remains a Buy, with valuation reflecting LOE risks and attractive risk-reward as the company executes on post-LOE growth strategies. PFE delivered a strong quarter, raising revenue guidance to

Connecting Excellence Group Plc (AQSE:XCE, OTCQB:XCELF) announced it has raised £600,000 through a share subscription to fund its Bitcoin treasury, acquisition strategy and hiring plans, with strategi

Shopify partners with Meta to enable Muse AI-driven purchases via Shop Pay after Amazon blocks Muse from its platform. Alibaba advances its AI ambitions, detailing the Qwen 4 model in training and pla

WisdomAI's agentic analytics platform — natively embedded in Tera — delivers natural-language analytics, single-prompt Live Apps, and proactive AI agents across all enterprise data, achieving 95%+ ins

Oracle laid off over 500 US employees from its cloud infrastructure division last week, per docs obtained by BI. The cuts fell hardest on managers, engineers, software developers, and data center supp

China's gold imports hit a monthly high in August, with the standout performance helping to push the country's gold imports to a record high over 1,100 tonnes year-to-date, China's General Administrat

Genmab A/S (GMAB) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Insmed is rated Buy, driven by Brinsupri's blockbuster launch and strong TPIP Phase 2b data. Brinsupri generated $517m in 1H 2026, faces minimal competition, and targets $7bn+ peak sales with COPD/ast

I rate AN2 Therapeutics a speculative buy, with a risk-adjusted base-case valuation of approximately $12 per share versus its September 18 closing price of $5.05. Epetraborole failed in treatment-refr

For most of the past two years, NVIDIA Corporation NASDAQ: NVDA has stood at the summit of the stock market. As the chipmaker whose processors power much of the artificial intelligence boom, it was pe